SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 4, Issue 4, 2015, Pages

Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy

(5) Ohkuri, Takayuki a Ghosh, Arundhati b,c Kosaka, Akemi a Sarkar, Saumendra N b,c Okada, Hideho d

a ASAHIKAWA MEDICAL COLLEGE (Japan)

b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE (United States)

c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE (United States)

d UNIVERSITY OF CALIFORNIA (United States)

Author keywords

Glioma; Immunotherapy; STING; Type I IFNs

Indexed keywords

CYCLIC GMP; CYTOKINE RECEPTOR AGONIST; GENOMIC DNA; INTERFERON; STIMULATOR OF INTERFERON AGONIST; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL GROWTH; CYTOKINE PRODUCTION; GENE; GLIOMA; IMMUNE RESPONSE; NONHUMAN; STING GENE; TUMOR MICROENVIRONMENT; UPREGULATION; VACCINATION;

EID: 84948687006 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.1080/2162402X.2014.999523 Document Type: Article

Times cited : (16)

References (7)

1
- 77954238185
- Role of type 1 IFNs in antiglioma immunosurveillance-using mouse studies to guide examination of novel prognostic markers in humans
- PMID:20472682
- Fujita M, Scheurer ME, Decker SA, McDonald HA, Kohanbash G, Kastenhuber ER, Kato H, Bondy ML, Ohlfest JR, Okada H. Role of type 1 IFNs in antiglioma immunosurveillance-using mouse studies to guide examination of novel prognostic markers in humans. Clin Cancer Res 2010; 16:3409-19; PMID:20472682; http://dx. doi. org/10. 1158/1078-0432. CCR-10-0644
- (2010) Clin Cancer Res , vol.16 , pp. 3409-3419
- Fujita, M.¹ Scheurer, M.E.² Decker, S.A.³ McDonald, H.A.⁴ Kohanbash, G.⁵ Kastenhuber, E.R.⁶ Kato, H.⁷ Bondy, M.L.⁸ Ohlfest, J.R.⁹ Okada, H.¹⁰

2
- 84964698449
- STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment
- PMID:25300859
- Ohkuri T, Ghosh A, Kosaka A, Zhu J, Ikeura M, David M, Watkins SC, Sarkar SN, Okada H. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment. Cancer Immunol Res 2014; 2:1199-208; PMID:25300859; http://dx. doi. org/10. 1158/2326-6066. CIR-14-0099
- (2014) Cancer Immunol Res , vol.2 , pp. 1199-1208
- Ohkuri, T.¹ Ghosh, A.² Kosaka, A.³ Zhu, J.⁴ Ikeura, M.⁵ David, M.⁶ Watkins, S.C.⁷ Sarkar, S.N.⁸ Okada, H.⁹

3
- 70349943834
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- PMID:19776740
- Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009; 461:788-92; PMID:19776740; http://dx. doi. org/10. 1038/ nature08476
- (2009) Nature , vol.461 , pp. 788-792
- Ishikawa, H.¹ Ma, Z.² Barber, G.N.³

4
- 84873711885
- Cyclic GMPAMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway
- PMID:23258413
- Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMPAMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013; 339:786-91; PMID:23258413; http://dx. doi. org/10. 1126/ science. 1232458
- (2013) Science , vol.339 , pp. 786-791
- Sun, L.¹ Wu, J.² Du, F.³ Chen, X.⁴ Chen, Z.J.⁵

5
- 84888637695
- Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP
- PMID:24077100
- Ablasser A, Schmid-Burgk JL, Hemmerling I, Horvath GL, Schmidt T, Latz E, Hornung V. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 2013; 503:530-4; PMID:24077100; http://dx. doi. org/10. 1038/ nature12640
- (2013) Nature , vol.503 , pp. 530-534
- Ablasser, A.¹ Schmid-Burgk, J.L.² Hemmerling, I.³ Horvath, G.L.⁴ Schmidt, T.⁵ Latz, E.⁶ Hornung, V.⁷

6
- 79958012952
- Identification and characterization of a loss-of-function human MPYS variant
- PMID:21248775
- Jin L, Xu LG, Yang IV, Davidson EJ, Schwartz DA, Wurfel MM, Cambier JC. Identification and characterization of a loss-of-function human MPYS variant. Genes Immun 2011; 12:263-9; PMID:21248775; http://dx. doi. org/10. 1038/gene. 2010. 75
- (2011) Genes Immun , vol.12 , pp. 263-269
- Jin, L.¹ Xu, L.G.² Yang, I.V.³ Davidson, E.J.⁴ Schwartz, D.A.⁵ Wurfel, M.M.⁶ Cambier, J.C.⁷

7
- 84964313767
- STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer
- PMID:24913717
- Chandra D, Quispe-Tintaya W, Jahangir A, Asafu-Adjei D, Ramos I, Sintim HO, Zhou J, Hayakawa Y, Karaolis DK, Gravekamp C. STING ligand c-di-GMP improves cancer vaccination against metastatic breast cancer. Cancer Immunol Res 2014; 2(9):901-10; PMID:24913717; http://dx. doi. org/10. 1158/ 2326-6066. CIR-13-0123
- (2014) Cancer Immunol Res , vol.2 , Issue.9 , pp. 901-910
- Chandra, D.¹ Quispe-Tintaya, W.² Jahangir, A.³ Asafu-Adjei, D.⁴ Ramos, I.⁵ Sintim, H.O.⁶ Zhou, J.⁷ Hayakawa, Y.⁸ Karaolis, D.K.⁹ Gravekamp, C.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.